Oculotrichoanal syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2717OMIM:248450Q87.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculotrichoanal (OTA) syndrome is an extremely rare congenital malformation syndrome characterized by the combination of eye (oculo-), hair (tricho-), and anal abnormalities. The condition was first described by Feingold and colleagues and has also been referred to as Feingold-Trainer syndrome or oculo-tricho-anal syndrome. Key clinical features include coloboma of the upper eyelid (often bilateral), aberrant anterior hairline with a low frontal hairline or unusual hair patterning extending onto the forehead, and anal anomalies including imperforate anus or anteriorly displaced anus. Additional features may include a broad or bifid nasal tip and other minor facial dysmorphisms. The syndrome primarily affects the craniofacial structures, the skin and hair, and the gastrointestinal/anorectal system. Eye findings typically involve eyelid colobomas rather than iris or retinal colobomas, which distinguishes this condition from some other coloboma-associated syndromes. The anal malformations can range from mild anterior displacement of the anus to complete imperforate anus requiring surgical correction in the neonatal period. Treatment is symptomatic and supportive. Surgical intervention may be necessary for imperforate anus (anoplasty) and for eyelid coloboma repair to protect the cornea and improve cosmesis. Long-term follow-up with ophthalmology and gastroenterology may be needed depending on the severity of the malformations. There is no cure for the underlying condition, and management focuses on addressing individual anomalies. Genetic counseling is recommended for affected families.

Also known as:

Clinical phenotype terms— hover any for plain English:

Bifid nasal tipHP:0000456AnophthalmiaHP:0000528Nasolacrimal duct obstructionHP:0000579Upper eyelid colobomaHP:0000636CryptophthalmosHP:0001126Anteriorly placed anusHP:0001545Anal stenosisHP:0002025Abnormal hair patternHP:0010720
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculotrichoanal syndrome.

View clinical trials →

No actively recruiting trials found for Oculotrichoanal syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculotrichoanal syndrome community →

No specialists are currently listed for Oculotrichoanal syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculotrichoanal syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculotrichoanal syndromeForum →

No community posts yet. Be the first to share your experience with Oculotrichoanal syndrome.

Start the conversation →

Latest news about Oculotrichoanal syndrome

No recent news articles for Oculotrichoanal syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Oculotrichoanal syndrome

What is Oculotrichoanal syndrome?

Oculotrichoanal (OTA) syndrome is an extremely rare congenital malformation syndrome characterized by the combination of eye (oculo-), hair (tricho-), and anal abnormalities. The condition was first described by Feingold and colleagues and has also been referred to as Feingold-Trainer syndrome or oculo-tricho-anal syndrome. Key clinical features include coloboma of the upper eyelid (often bilateral), aberrant anterior hairline with a low frontal hairline or unusual hair patterning extending onto the forehead, and anal anomalies including imperforate anus or anteriorly displaced anus. Additiona

How is Oculotrichoanal syndrome inherited?

Oculotrichoanal syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Oculotrichoanal syndrome typically begin?

Typical onset of Oculotrichoanal syndrome is neonatal. Age of onset can vary across affected individuals.